TuHURA Biosciences (HURA) Earnings Analysis

TuHURA Biosciences (HURA) next reports earnings on 2026-08-13, consensus EPS -0.15333 USD. Last quarter (2026-05-15) it missed with EPS -0.13 USD vs -0.12 USD est (-8.3%). It has beaten estimates in 1/7 recent quarters (14%). Trailing P/E -3.65.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does HURA next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.15333 USD
Revenue estimaten/a

HURA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-15-0.13 USD-0.12 USD-8.3%Miss
2026-03-31-0.125 USD-0.12333 USD-1.4%Miss
2025-11-14-0.14 USD-0.15 USD+6.7%Beat
2025-08-14-0.21 USD-0.14 USD-50%Miss
2025-05-15-0.15 USD-0.13 USD-15.4%Miss
2025-02-26-8.39 USD-0.09 USD-9222.2%Miss
2024-11-14-1.37 USD-0.1 USD-1270%Miss

Beat rate: 1/7 (14%) over reported quarters with consensus data.

HURA valuation and analyst view

Trailing P/E-3.65
Trailing EPS-0.51545 USD
Price / book5.80
Dividend yield0.00%
Market cap0.14B
Analyst consensusBuy (2 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is TuHURA Biosciences (HURA)'s next earnings date?

TuHURA Biosciences is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.15333 USD.

Did HURA beat earnings last quarter?

In its 2026-05-15 report, HURA posted EPS of -0.13 USD versus a -0.12 USD estimate — a miss of 8.3%.

What is HURA's earnings track record?

Over the last 7 reported quarters with consensus data, HURA beat estimates 1 times (14%).

What is HURA's current P/E ratio and EPS?

HURA trades at a trailing P/E of -3.65 on trailing EPS of -0.5154547215002667 USD.

What do analysts rate HURA?

Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell).